Thawing System Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 12.80 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Thawing System Market Analysis
The thawing system market studied is expected to register a CAGR of nearly 12.8% over the forecast period.
- The COVID-19 pandemic had a significant impact on the thawing system market, primarily due to the increased utilization of thawing systems for transporting vaccines and swabs to keep them viable for testing. For example, a December 2022 article published in MedRxiv notes that ultra-low temperature preservation has been the gold standard for the long-term storage of several types of clinical specimens, including the SARS-CoV-2 virus. Frozen specimens are easily transportable and can be analyzed at a later date, and de-identified frozen residual samples can be used in a variety of preclinical and clinical research.
- Additionally, freezing and thawing do not significantly affect the testing results when making dilutions or testing clinical samples on rapid test kits. Therefore, COVID-19 had a significant impact on the thawing system market. However, with the resumption of laboratory services and decreasing cases of COVID-19, the studied market is expected to witness stable growth over the forecast period.
- The major factors driving the growth of the market include increasing usage of thawing devices in various applications and increasing demand for thawed cells for the treatment of different diseases. Furthermore, the growing investments in research and development programs by biotechnology and pharmaceutical companies are boosting market growth. For instance, an April 2022 article published in PubMed suggests that targeted research into optimizing cryopreservation and freeze-thawing routines, as well as the design of adjunct manufacturing processes, may provide critical advantages in improving the safety and efficacy of cellular therapeutics in clinical use. This research also enables effective market deployment strategies to become economically viable and sustainable medicines.
- Furthermore, many comparative studies with thawing systems and technological advancements are likely to increase the utilization of the thawing system. For example, in November 2022, BioLife Solutions, Inc., a developer, and supplier of class-defining bioproduction products and services for cell and gene therapy (CGT) and the broader biopharma markets, provided an update on the expansion of its intellectual property estate. The company received notice of the granting of seven patents by the USPTO and other patent authorities outside the United States and filed 43 new applications for novel inventions related to its cell processing, media, storage containers, freezers, and thaw systems platforms, several of which are specific to BioLife's proprietary Stirling engine technologies.
- In December 2021, Sartorius and HOF Sonderanlagenbau entered into a partnership to integrate two HOF horizontal plate freeze-thaw units into Sartorius' portfolio, offering customers a full suite of compatible freeze-thaw equipment and consumables. This partnership enabled faster and easier implementation of robust frozen drug substance management platforms through improved validation and purchase support from a single supplier.
- Thus, with the increase in demand for thawing systems and rapid technological advancements, the studied market is expected to witness significant growth over the forecast period. However, the high cost of automatic devices remains a major drawback to market growth.
Thawing System Market Trends
Blood Segment is Anticipated to Witness a Growth in the Market Over the Forecast Period
- The blood sample segment is poised to experience significant growth in the studied market due to several factors, including the rising incidence of hematological diseases, an increase in research studies, rapid technological advancements, and a greater awareness of the benefits of plasma therapy. For example, according to an article published in PubMed in November 2022, researchers demonstrated that plasma samples subjected to up to 10 freeze-thaw cycles with quick freezing and thawing exhibited remarkably stable metabolite levels. These results are expected to inform future workflows for preparing plasma samples for metabolomics analyses.
- Furthermore, an increase in hematological diseases and the need for plasma therapy are likely to boost market growth during the forecast period. Additionally, a high prevalence of blood donation and transfusion is contributing to segment growth. For instance, according to a 2022 update from the Health Sciences Authority (HSA) of Singapore, in 2021, the HSA collected 114.5 thousand whole blood and 9.5 thousand apheresis donations, while 69 thousand people donated blood in Singapore in 2021. As the number of blood donations increases, the donated blood stores in the blood bank, which in turn, drives demand for the segment during the forecast period.
- Moreover, the approval of products is also driving the growth of the market segment. For example, in July 2020, FreMon Scientific received clearance from the United States Food and Drug Administration (FDA) for ZipThaw, a Class II medical device for frozen plasma thawing. ZipThaw, when used with the ZipSleeve anti-contaminant disposable barrier, is one of the world's first dry and portable precision plasma thawing systems.
- Therefore, the combination of increased demand for blood thawing systems and rapid technological advancements is expected to drive significant growth in the studied segment during the forecast period.
North America Anticipated to Hold a Significant Market Share Over the Forecast Period
- North America is anticipated to maintain a noteworthy market share throughout the forecast period due to several factors, such as the development of blood bank and biobank infrastructure, rising research activities in regenerative medicine, cell and gene therapy, increasing interest in customized medicine and biomarker discovery, and a growing number of biotechnology and pharmaceutical companies, as well as increasing government funding.
- For example, as per the estimates of the American National Red Cross in October 2021, around 36,000 units of red blood cells are required every day, and nearly 25 million blood components are transfused each year in the United States. Since thawed plasma is widely stored in blood banks to maintain its viability, the need for defrosting arises when necessary, and thawing systems are likely to be utilized more frequently, thereby fueling market growth during the forecast period.
- Moreover, an increase in strategic activities by key players and product launches is also expected to drive market growth. Thermo Fisher, for instance, launched Controlled-Rate Freezers in January 2021, providing optimal sample protection. CryoMed Freezers offer repeatable, consistent temperature performance, enhanced data traceability, and support GMP and 21 CFR Part 11 requirements.
- As a result of the rise in demand for thawing systems and the rapid advancement of technology, North America is expected to witness significant growth in the market during the forecast period.
Thawing System Industry Overview
The thawing system market is consolidated and consists of a few major players. Key players are focused on strategic plans such as product launches, partnerships, acquisitions, and mergers to increase their presence across the regions. Some of the companies which are currently dominating the market are Sartorius AG, BioCision., CytoTherm, Boekel Scientific, Helmer Scientific Inc., Cardinal Health, Barkey GmbH & Co. KG, Helmer Scientific, Sarstedt.
Thawing System Market Leaders
-
Sartorius AG
-
Cardinal Health
-
Boekel Scientific
-
Helmer Scientific Inc.
-
Thermo Fisher Scientific
*Disclaimer: Major Players sorted in no particular order
Thawing System Market News
- September 2022: Entegris partnered with Farrar Scientific by Trane Technologies, a global climate innovator. Farrar offers operating systems for ultra-cold temperature storage and controlled rate freeze/thaw chambers for pharmaceutical, biotech, and biorepository applications. Entegris offers an Aramus bag for robust cold storage and transport. Collaborating with Farrar enables Entegris to offer a combined solution that accelerates the freeze/thaw process.
- September 2022: Entegris partnered with HOF Sonderanlagenbau GmbH, an international provider of freeze/thaw equipment and special solutions for the pharmaceutical and biotechnology sectors. Entegris offers the best-in-class Aramus bag for robust cold storage and transport. Collaborating with HOF enables Entegris to offer a combined solution for customers that accelerate the freeze/thaw process and help showcase the new Life Sciences Technology Center, built to offer customers the opportunity to leverage the cold-chain supply expertise to optimize processes, reduce costs, and increase speed to market.
Thawing System Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Usage of Thawing System in the Biopharmaceuticals Industry
- 4.2.2 Increasing Demand for Thawed Cells
-
4.3 Market Restraints
- 4.3.1 High Cost of Automation
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Device Type
- 5.1.1 Manual Devices
- 5.1.2 Automated Devices
-
5.2 By Sample
- 5.2.1 Blood
- 5.2.2 Embryos
- 5.2.3 Ovum
- 5.2.4 Other Samples
-
5.3 By End-User
- 5.3.1 Hospitals & Diagnostic Laboratories
- 5.3.2 Blood Banks & Transfusion Centers
- 5.3.3 Other End-Users
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Sartorius AG
- 6.1.2 BioCision
- 6.1.3 CytoTherm
- 6.1.4 Boekel Scientific
- 6.1.5 Helmer Scientific Inc.
- 6.1.6 Cardinal Health
- 6.1.7 Barkey GmbH & Co. KG
- 6.1.8 Helmer Scientific
- 6.1.9 Sarstedt
- 6.1.10 REMI GROUP
- 6.1.11 Stericox India Private Limited
- 6.1.12 Terumo Corporation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityThawing System Industry Segmentation
As per the scope of the report, thawing systems are used for defrosting biological samples such as plasma, stem cells, etc. Thawing refers to the process of taking a frozen product to a temperature where there is no residual ice. This process is also called defrosting and is simply the opposite of freezing.
The thawing system market is segmented by device type (manual devices, automated devices), sample (blood, embryos, ovum, and other samples), end-user (hospitals & diagnostic laboratories, blood banks & transfusion centers, other end-users), and geography (North America, Europe, Asia-Pacific, Middle East, and Africa, South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally.
The report offers the value (in USD) for the above segments.
| By Device Type | Manual Devices | |
| Automated Devices | ||
| By Sample | Blood | |
| Embryos | ||
| Ovum | ||
| Other Samples | ||
| By End-User | Hospitals & Diagnostic Laboratories | |
| Blood Banks & Transfusion Centers | ||
| Other End-Users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Thawing System Market Research FAQs
What is the current Thawing System Market size?
The Thawing System Market is projected to register a CAGR of 12.80% during the forecast period (2024-2029)
Who are the key players in Thawing System Market?
Sartorius AG, Cardinal Health, Boekel Scientific, Helmer Scientific Inc. and Thermo Fisher Scientific are the major companies operating in the Thawing System Market.
Which is the fastest growing region in Thawing System Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Thawing System Market?
In 2024, the North America accounts for the largest market share in Thawing System Market.
What years does this Thawing System Market cover?
The report covers the Thawing System Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Thawing System Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Thawing System Industry Report
Statistics for the 2023 Thawing System market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Thawing System analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
